CPDR ISSUED U.S. PATENTS

Prostate Cancer-Specific Alterations in ERG Gene Expression and Detection and Treatment Methods Based on Those Alterations
U.S.: Patent serial #12/444,903. Claims for EPC-1 and 2 issued September 2013.Complete
Document

Prostate Cancer-Specific Alterations in ERG Gene Expression and Detection and Treatment Methods Based on Those Alterations
Australia: Patent # 2007324128 has issued ERG-8 claims in January 2014.Complete
Document

Prostate Cancer-Specific Alterations in ERG Gene Expression and Detection and Treatment Methods Based on Those Alterations
Japan: Patent # 5470041, has issued ERG-8 in February 2014.

Prostate Cancer-Specific Alterations in ERG Gene Expression and Detection and Treatment Methods Based on Those Alterations
European Union: EPC-1 issued, serial # 12163605.4.